Related content

Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells

By Huang Fang   Wu Xiao-Nan   Chen Jie   Wang Wen-Xiang   Lu ZuFu  

Experimental and Therapeutic Medicine, Vol. 7, Iss. 6, 2014-06 ,pp. : 1611-1616

Spandidos Publications

Access to resources Recommend Favorite

Loperamide, an FDA-Approved Antidiarrhea Drug, Effectively Reverses the Resistance of Multidrug Resistant MCF-7/MDR1 Human Breast Cancer Cells to Doxorubicin-Induced Cytotoxicity

By Zhou Yanfei   Sridhar Rajagopalan   Shan Liang   Sha Wei   Gu Xinbin   Sukumar Saraswati  

Cancer Investigation, Vol. 30, Iss. 2, 2012-02 ,pp. : 119-125

Informa Healthcare

Access to resources Recommend Favorite

The Experimental Antitumor Agents Phortress and Doxorubicin are Equiactive Against Human‐Derived Breast Carcinoma Xenograft Models

By Fichtner Iduna  

Breast Cancer Research and Treatment, Vol. 87, Iss. 1, 2004-09 ,pp. : 97-107

Springer Publishing Company

Access to resources Recommend Favorite

MEDI3617, a human anti-Angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models

By                              

International Journal of Oncology, Vol. 40, Iss. 5, 2012-01 ,pp. : 1321-1330

Spandidos Publications

Access to resources Recommend Favorite

Piperlongumine reverses doxorubicin resistance through the PI3K/Akt signaling pathway in K562/A02 human leukemia cells

By    

Experimental and Therapeutic Medicine, Vol. 9, Iss. 4, 2015-01 ,pp. : 1345-1350

Spandidos Publications

Access to resources Recommend Favorite